Discovering drugs to treat coronavirus disease 2019 (COVID-19)
-
- Dong Liying
- Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
-
- Hu Shasha
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
-
- Gao Jianjun
- Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
Search this article
Abstract
<p>The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.</p>
Journal
-
- Drug Discoveries & Therapeutics
-
Drug Discoveries & Therapeutics 14 (1), 58-60, 2020-02-29
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
